ArticleActa neurologica Belgica2025
Headache symptoms in children and adolescents with ADHD: evaluating family history and the role of methylphenidate treatment.
Article in Acta neurologica Belgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundClinical and epidemiological studies have reported a comorbidity between Attention Deficit Hyperactivity Disorder (ADHD) and migraine. Pharmacological treatments such as methylphenidate have also been hypothesized to contribute to the onset of headaches. This study aimed to investigate the percentage of headaches in a pediatric ADHD population, comparing children treated with methylphenidate to those not receiving pharmacological therapy, while also considering the potential influence of family history, sex, and age.
methodsA retrospective cross-sectional analysis was conducted on 118 children and adolescents diagnosed with ADHD (68 treated with methylphenidate, 50 untreated). Headache presence and features were assessed using a structured questionnaire based on international diagnostic criteria. Binomial and multinomial logistic regressions were used to evaluate the effects of methylphenidate use and family history on headache presence and type, controlling for age and sex.
resultsHeadache symptoms were significantly more frequent in participants with a family history of headache, regardless of medication status. No main effect of methylphenidate on overall headache percentage was observed. However, the combination of methylphenidate treatment and positive family history was significantly associated with migraine-compatible headache presentations. Cephalalgy was not significantly linked to any of the variables. The absence of family history was strongly associated with the absence of headache symptoms.
conclusionsFamily history appears to be a key factor in headache percentage among children with ADHD. While methylphenidate alone does not increase headache risk, its interaction with familial predisposition may contribute to migraine-like symptoms. Family history should be carefully considered during clinical assessment.
Indexed as
Identifiers
41107673What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.